HighMark Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.45K | Sell |
10
-1
| -9% | -$445 | ﹤0.01% | 409 |
|
|
2025
Q1 | $5.33K | Hold |
11
| – | – | ﹤0.01% | 363 |
|
|
2024
Q4 | $4.43K | Hold |
11
| – | – | ﹤0.01% | 390 |
|
|
2024
Q3 | $5.12K | Sell |
11
-11
| -50% | -$5.12K | ﹤0.01% | 403 |
|
|
2024
Q2 | $10.3K | Buy |
22
+11
| +100% | +$5.16K | 0.01% | 273 |
|
|
2024
Q1 | $4.6K | Hold |
11
| – | – | ﹤0.01% | 386 |
|
|
2023
Q4 | $4.48K | Sell |
11
-4
| -27% | -$1.63K | ﹤0.01% | 386 |
|
|
2023
Q3 | $5.22K | Buy |
15
+3
| +25% | +$1.04K | ﹤0.01% | 346 |
|
|
2023
Q2 | $0 | Buy |
+12
| New | – | ﹤0.01% | 619 |
|
|
2021
Q3 | – | Sell |
-19
| Closed | -$5K | – | 530 |
|
|
2021
Q2 | $5K | Sell |
19
-24
| -56% | -$6.32K | ﹤0.01% | 379 |
|
|
2021
Q1 | $9K | Buy |
43
+2
| +5% | +$419 | 0.01% | 256 |
|
|
2020
Q4 | $10K | Hold |
41
| – | – | 0.01% | 237 |
|
|
2020
Q3 | $11K | Hold |
41
| – | – | 0.01% | 218 |
|
|
2020
Q2 | $12K | Sell |
41
-7
| -15% | -$2.05K | 0.01% | 179 |
|
|
2020
Q1 | $11K | Sell |
48
-14
| -23% | -$3.21K | 0.01% | 148 |
|
|
2019
Q4 | $13K | Buy |
+62
| New | +$13K | 0.01% | 171 |
|